157 related articles for article (PubMed ID: 8149971)
1. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro.
Herbert JM; Delisée C; Dol F; Schaeffer P; Cazaubon C; Nisato D; Chatelain P
Eur J Pharmacol; 1994 Jan; 251(2-3):143-50. PubMed ID: 8149971
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved.
Jaiswal N; Tallant EA; Jaiswal RK; Diz DI; Ferrario CM
J Pharmacol Exp Ther; 1993 May; 265(2):664-73. PubMed ID: 8496814
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
Catalioto RM; Porchia R; Renzetti AR; Criscuoli M; Subissi A; Giachetti A
Eur J Pharmacol; 1995 Jul; 280(3):285-92. PubMed ID: 8566096
[TBL] [Abstract][Full Text] [Related]
5. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
[TBL] [Abstract][Full Text] [Related]
6. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
8. Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signalling system in vascular smooth muscle cells.
Ko Y; Görg A; Appenheimer M; Wieczorek AJ; Düsing R; Vetter H; Sachinidis A
Eur J Pharmacol; 1992 Oct; 227(2):215-9. PubMed ID: 1426030
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
10. EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells.
Sachinidis A; Ko Y; Weisser P; Meyer zu Brickwedde MK; Düsing R; Christian R; Wieczorek AJ; Vetter H
J Hypertens; 1993 Feb; 11(2):155-62. PubMed ID: 8385175
[TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells.
Makita S; Nakamura M; Yoshida H; Hiramori K
Life Sci; 1995; 56(20):PL383-8. PubMed ID: 7723594
[TBL] [Abstract][Full Text] [Related]
12. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
[TBL] [Abstract][Full Text] [Related]
13. Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation.
Freeman EJ; Tallant EA
Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):543-8. PubMed ID: 7998990
[TBL] [Abstract][Full Text] [Related]
14. [125I]EXP985: a highly potent and specific nonpeptide radioligand antagonist for the AT1 angiotensin receptor.
Chiu AT; McCall DE; Roscoe WA
Biochem Biophys Res Commun; 1992 Nov; 188(3):1030-9. PubMed ID: 1445340
[TBL] [Abstract][Full Text] [Related]
15. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.
Nozawa Y; Matsuura N; Miyake H; Yamada S; Kimura R
Life Sci; 1999; 64(22):2061-70. PubMed ID: 10374931
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cardiac angiotensin AT1 receptors by [3H]SR 47436.
Delisée C; Schaeffer P; Cazaubon C; Chatelain P
Eur J Pharmacol; 1993 Oct; 247(2):139-44. PubMed ID: 8282003
[TBL] [Abstract][Full Text] [Related]
17. HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro.
Dunn FW; Roux MH; Farhadian F; Sabri K; Ossart C; Samuel JL; Rappaport L; Hamon G
J Pharmacol Exp Ther; 1997 Jan; 280(1):447-53. PubMed ID: 8996227
[TBL] [Abstract][Full Text] [Related]
18. In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
Chang RS; Siegl PK; Clineschmidt BV; Mantlo NB; Chakravarty PK; Greenlee WJ; Patchett AA; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):133-8. PubMed ID: 1625192
[TBL] [Abstract][Full Text] [Related]
19. Novel angiotensin receptor subtypes in fowl.
Nishimura H; Walker OE; Patton CM; Madison AB; Chiu AT; Keiser J
Am J Physiol; 1994 Nov; 267(5 Pt 2):R1174-81. PubMed ID: 7977843
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]